<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision loss — Live Feed</title><link>https://www.live-feeds.com/feed/hundreds-of-lawsuits-allege-glp-1s-like-ozempic-wegovy-mounjaro-caused-vision-loss</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/hundreds-of-lawsuits-allege-glp-1s-like-ozempic-wegovy-mounjaro-caused-vision-loss/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Hundreds of lawsuits link GLP-1 drugs to permanent vision loss</title><link>https://www.live-feeds.com/feed/hundreds-of-lawsuits-allege-glp-1s-like-ozempic-wegovy-mounjaro-caused-vision-loss</link><guid isPermaLink="false">https://www.live-feeds.com/feed/hundreds-of-lawsuits-allege-glp-1s-like-ozempic-wegovy-mounjaro-caused-vision-loss#u82816</guid><pubDate>Thu, 24 Sep 2026 18:40:33 +0000</pubDate><description>Hundreds of patients are suing manufacturers of GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound, alleging the drugs caused permanent vision loss. The litigation specifically links these weight-loss and diabetes medications to non-arteritic anterior ischemic optic neuropathy, a rare condition described as an eye stroke. Plaintiffs claim the drugs triggered sudden sight loss, leading to numerous legal filings against the pharmaceutical companies. While the condition is rare, the volume of lawsuits suggests a growing pattern of reported ocular complications among users of the</description></item>
</channel></rss>